Cargando…
The correlation between fibroblast growth factor-23 and ESRD patients with hearing impairment
BACKGROUND: End-stage renal disease (ESRD) patients often experience hearing impairment, resulting in a high rate of disability and a decline in their quality of life. Fibroblast growth factor-23 (FGF23) is a diagnostic biomarker for chronic kidney disease (CKD) and a pathogenic contributor to CKD p...
Autores principales: | Nie, Jingwen, Li, Qing, Guo, Min, Li, Jiaqing, Yang, Jiahui, Chang, Qing, Cai, Yaping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520394/ https://www.ncbi.nlm.nih.gov/pubmed/34721981 http://dx.doi.org/10.7717/peerj.12295 |
Ejemplares similares
-
Correlation study of FGF23/D-serine in maintenance hemodialysis patients with combined hearing impairment
por: Yuan, Dunlu, et al.
Publicado: (2023) -
Epidemiological features for primary lymphoma of the female genital tract patients and development of a nomogram to predict survival
por: Peng, Fei, et al.
Publicado: (2022) -
Elevated Fibroblast Growth Factor 23 Levels Are Associated With Greater Diastolic Dysfunction in ESRD
por: Sharma, Shilpa, et al.
Publicado: (2019) -
Retrospective correlation analysis of plasma Immunoglobulin G and clinical performance in CIDP
por: Markvardsen, Lars Kjøbsted, et al.
Publicado: (2019) -
Correlation Between Serum Ferritin and Degree of Hepatic Fibrosis on Fibroscan in Thalassemic Patients
por: Ali, Muhammad Shujat, et al.
Publicado: (2023)